Copyright
©The Author(s) 2018.
World J Clin Oncol. Nov 10, 2018; 9(7): 140-147
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.140
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.140
Table 2 Baseline characteristics of the study population n (%)
Characteristic | Total, n = 1501 |
Age in yr | 58.4 (10.8) |
Males | 1236 (82.3) |
Smokers | 1155 (76.9) |
Body mass index in kg/m2 | 20.2 (4.2) |
Histopathology | |
NSCLC: Squamous | 553 (36.8) |
NSCLC: Adeno | 514 (34.2) |
NSCLC: Undifferentiated | 87 (5.8) |
NSCLC: Other | 42 (2.8) |
SCLC | 305 (20.3) |
NSCLC/SCLC stage1 | |
I and II | 44 (2.9) |
IIIA | 193 (12.9) |
IIIB | 426 (28.4) |
IV | 767 (51.1) |
SCLC stage | |
Limited disease | 145 (9.7) |
Extensive disease | 160 (10.7) |
Baseline performance status | |
KPS | 77.6 (14.4) |
ECOG PS | 1.5 (1) |
- Citation: Prasad KT, Kaur H, Muthu V, Aggarwal AN, Behera D, Singh N. Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients. World J Clin Oncol 2018; 9(7): 140-147
- URL: https://www.wjgnet.com/2218-4333/full/v9/i7/140.htm
- DOI: https://dx.doi.org/10.5306/wjco.v9.i7.140